SIGN UP FOR UPDATES!
Sign up for Englemed updates from TwitterSign up for Englemed updates from Facebook
ENGLEMED
Contact Englemed
Our contact email address.
We can provide a specialist, tailored health and medical news service for your site.
Click here for more information
RSS graphic XML Graphic Add to Google
About Englemed news services - services and policies.
Englemed News Blog - Ten years and counting.
Diary of a reluctant allergy sufferer - How the British National Health Service deals with allergy.
BOOKS AND GIFTS THIS WAY!
BookshopFor books on women's health, healthy eating ideas, mental health issues, diabetes, etc click here
SEARCH THIS SITE
Copyright Notice. All reports, text and layout copyright Englemed Ltd, 52 Perry Avenue, Birmingham UK B42 2NE. Co Registered in England No 7053778 Some photos copyright Englemed Ltd, others may be used with permission of copyright owners.
Disclaimer: Englemed is a news service and does not provide health advice. Advice should be taken from a medical professional or appropriate health professional about any course of treatment or therapy.
FreeDigitalPhotos
www.freedigitalphotos.net
FreeWebPhotos
www.freewebphoto.com
FROM OUR NEWS FEEDS
Glioblastoma hope from Leeds tests
Thurs Aug 16th - British scientists have identified a promising chemical treatment for aggressive brain tumours, it has been announced. More
Possible liver failure prevention drug unveiled
Thurs Aug 16th - A promising new treatment has been found for sudden liver failure, according to research reported last night. More
RECENT COMMENTS
On 08/02/2018 David Kelly wrote:
Would you like to write a piece about this to be i... on Researchers unveil new pain re...
On 23/10/2017 Cristina Pereira wrote:
https://epidemicj17.imascientist.org.uk/2017/06/21... on HIV breakthrough - MRC...
On 12/09/2017 Aparna srikantam wrote:
Brilliant finding! indeed a break through in under... on Leprosy research breakthrough...
On 01/07/2017 Annetta wrote:
I have been diagnosed with COPD for over 12 years.... on Seaweed plan for antimicrobial...
On 12/03/2017 Steph wrote:
The photo you have paired with this article is its... on 'Fat shaming' limits...
BOOKS ON WOMEN'S HEALTH
guide to breast disorders guide to womb disorders guide to menopause Complete Women's Health: from The Royal College of Obstetricians and Gynaecologists For more books and family gift ideas click here
OTHER NEWS OF INTEREST
WOMEN'S HEALTH NEWS FEED
RSS graphic XML Graphic
ENGLEMED HEALTH NEWS

Pregnant women can take some RA drugs

Friday May 18th, 2018

Pregnant women with rheumatoid arthritis (RA) could use specific drugs to treat their condition without increasing the health risks to their unborn babies, according to a new Canadian study.

Research led by the Research Institute of the McGill University Health Centre (RI-MUHC) in Montreal, Quebec, found that tumour necrosis factors inhibitors (TNFs), which are commonly used to reduce inflammation and relieve pain, did not expose babies to any significant excess risk of serious side effects compared to unexposed children from mothers with RA and children from the general population.

The research findings are published in the latest edition of Arthritis & Rheumatology.

First author Dr Évelyne Vinet and her team from the Centre for Outcomes of Evaluative Research (CORE) showed that although TNFs cross the placenta, the drug may not increase immunosuppression nor compromise the child's ability to fight infections.

"Knowing there is not necessarily an association between infections and these RA drugs will be very reassuring to expectant mothers," said Dr Vinet, an assistant professor in the Department of Medicine and Division of Rheumatology at the Faculty of Medicine of McGill University.

"It is important to highlight these findings so would-be mothers understand they can enjoy a normal pregnancy without being burdened by unnecessary stress."

The team studied nearly 3,000 children from mothers with RA and a random selected group of nearly 15,000 children during their first year of life. They defined TNFi exposure based on at least one filled prescription during pregnancy.

Within the RA group, 380 children were exposed to TNFs and 3.2% presented serious infections, compared to 2% among those who had no exposure to TNFs and 1.9% in the control group.

“Our study provides new evidence to counsel RA women contemplating pregnancy,” said Dr Vinet.

“Within the largest cohort of RA offspring exposed to TNFis ever assembled, we did not observe a marked excess risk for serious infections versus unexposed RA offspring and children from the general population.

“Our data are potentially reassuring, however, we could not exclude a differential risk according to specific TNFi characteristics, with infliximab potentially resulting in a three-fold increase in the risk of serious infections compared with other TNFis.”

Vinet E, De Moura C, Pineau C et al. Serious infections in rheumatoid arthritis offspring exposed to tumour necrosis factor a inhibitors: cohort study. Arthritis & Rheumatology 17 May, 2018; doi: 10.1002/art.40536.

http://doi.wiley.com/10.1002/art.40536

Tags: Childbirth and Pregnancy | North America | Pharmaceuticals | Rheumatology | Women's Health & Gynaecology

Printer friendly page Printer friendly page

Comment on this article:

Name:
Email:
Comment:
<a>,<b> & <p> tags allowed
Please enter the letters displayed:
(not case sensitive)
CATEGORIES